KLAC vs NVDA

KLAC demonstrates exceptional operational health with a Piotroski F-Score of 7/9 and a remarkable ROE of 100.73%. However, the stock is severely overvalued from a deterministic standpoint, trading at $1808.97—well above its Graham Number ($179.53) and growth-based Intrinsic Value ($1013.91). While earnings growth is robust at 40.9%, the combination of a bearish technical trend (10/100) and insider selling by the CEO and CFO suggests the current price has decoupled from fundamental value. The stock is currently a high-quality company trading at an unsustainable premium.

NVDA exhibits strong financial health with a Piotroski F-Score of 7/9, indicating robust operational efficiency and solvency. While the current price of $182.08 is significantly above the Graham Number ($26.71) and the growth-based intrinsic value ($144.55), the stock is fundamentally undervalued relative to its growth, as evidenced by a PEG ratio of 0.72 and a highly attractive Forward P/E of 16.38. The company's elite profitability margins (55.6% profit margin) and minimal debt (0.07 D/E) provide a massive cushion for volatility. Despite bearish insider sentiment and short-term technical weakness, the long-term growth trajectory remains exceptionally strong.